News

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The US Food and Drug Administration will require all new vaccines go through placebo-controlled studies before they are ...
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine — the nation's only traditional ...
The FDA may be making changes to how it handles COVID-19 booster shots. The agency’s top official says they’re taking a ...
Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...
FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.
Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...
In an interview with Dr. Phil, the health secretary offered false information about vaccine oversight and revealed a lack of ...
A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...
Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...
Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine after the agency grants full approval. The company said it had responded ...